Humana Statistics
Total Valuation
Humana has a market cap or net worth of $33.07 billion. The enterprise value is $43.30 billion.
Important Dates
The next confirmed earnings date is Wednesday, April 30, 2025, before market open.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Humana has 120.69 million shares outstanding. The number of shares has decreased by -2.87% in one year.
| Current Share Class | 120.69M |
| Shares Outstanding | 120.69M |
| Shares Change (YoY) | -2.87% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 97.98% |
| Float | 120.43M |
Valuation Ratios
The trailing PE ratio is 27.45 and the forward PE ratio is 16.72. Humana's PEG ratio is 1.73.
| PE Ratio | 27.45 |
| Forward PE | 16.72 |
| PS Ratio | 0.28 |
| Forward PS | 0.26 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 6.20 |
| P/FCF Ratio | 13.75 |
| P/OCF Ratio | 11.08 |
| PEG Ratio | 1.73 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 12.92, with an EV/FCF ratio of 18.11.
| EV / Earnings | 35.87 |
| EV / Sales | 0.37 |
| EV / EBITDA | 12.92 |
| EV / EBIT | 14.23 |
| EV / FCF | 18.11 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.77.
| Current Ratio | 1.76 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 3.56 |
| Debt / FCF | 5.29 |
| Interest Coverage | 4.61 |
Financial Efficiency
Return on equity (ROE) is 7.41% and return on invested capital (ROIC) is 6.56%.
| Return on Equity (ROE) | 7.41% |
| Return on Assets (ROA) | 4.07% |
| Return on Invested Capital (ROIC) | 6.56% |
| Return on Capital Employed (ROCE) | 10.30% |
| Revenue Per Employee | $1.79M |
| Profits Per Employee | $18,377 |
| Employee Count | 65,680 |
| Asset Turnover | 2.52 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $413.00 million in taxes.
| Income Tax | 413.00M |
| Effective Tax Rate | 25.38% |
Stock Price Statistics
The stock price has decreased by -21.39% in the last 52 weeks. The beta is 0.58, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -21.39% |
| 50-Day Moving Average | 271.47 |
| 200-Day Moving Average | 304.05 |
| Relative Strength Index (RSI) | 58.49 |
| Average Volume (20 Days) | 1,458,628 |
Short Selling Information
The latest short interest is 3.66 million, so 3.03% of the outstanding shares have been sold short.
| Short Interest | 3.66M |
| Short Previous Month | 4.58M |
| Short % of Shares Out | 3.03% |
| Short % of Float | 3.04% |
| Short Ratio (days to cover) | 2.05 |
Income Statement
In the last 12 months, Humana had revenue of $117.76 billion and earned $1.21 billion in profits. Earnings per share was $9.98.
| Revenue | 117.76B |
| Gross Profit | 17.10B |
| Operating Income | 3.04B |
| Pretax Income | 2.37B |
| Net Income | 1.21B |
| EBITDA | 3.35B |
| EBIT | 3.04B |
| Earnings Per Share (EPS) | $9.98 |
Full Income StatementBalance Sheet
The company has $20.44 billion in cash and $12.65 billion in debt, giving a net cash position of -$10.43 billion or -$86.38 per share.
| Cash & Cash Equivalents | 20.44B |
| Total Debt | 12.65B |
| Net Cash | -10.43B |
| Net Cash Per Share | -$86.38 |
| Equity (Book Value) | 16.45B |
| Book Value Per Share | 135.73 |
| Working Capital | 12.88B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $2.97 billion and capital expenditures -$575.00 million, giving a free cash flow of $2.39 billion.
| Operating Cash Flow | 2.97B |
| Capital Expenditures | -575.00M |
| Free Cash Flow | 2.39B |
| FCF Per Share | $19.81 |
Full Cash Flow StatementMargins
Gross margin is 14.52%, with operating and profit margins of 2.58% and 1.02%.
| Gross Margin | 14.52% |
| Operating Margin | 2.58% |
| Pretax Margin | 1.38% |
| Profit Margin | 1.02% |
| EBITDA Margin | 2.85% |
| EBIT Margin | 2.58% |
| FCF Margin | 2.03% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 1.29%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 35.47% |
| Buyback Yield | 2.87% |
| Shareholder Yield | 4.17% |
| Earnings Yield | 3.67% |
| FCF Yield | 7.27% |
Dividend DetailsAnalyst Forecast
The average price target for Humana is $289.05, which is 5.50% higher than the current price. The consensus rating is "Hold".
| Price Target | $289.05 |
| Price Target Difference | 5.50% |
| Analyst Consensus | Hold |
| Analyst Count | 22 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 33.56% |
Stock ForecastsStock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |